From Seekingalpha · SA Transcripts · · 40s
Disc Medicine Shares APOLLO Trial Results
Disc Medicine reports bitopertin trial success for EPP treatment.
In brief
Disc Medicine reports bitopertin trial success for EPP treatment. Disc Medicine Inc. (IRON) announced positive top-line results from its APOLLO Phase III trial of bitopertin for EPP. Originally reported by Seekingalpha.
Disc Medicine Inc.
Disc Medicine Inc. (IRON) published a slide deck discussing top-line results from its APOLLO Phase III trial of bitopertin for EPP.
APOLLO Phase III Trial
The trial tested bitopertin for EPP, a rare genetic disorder affecting the liver.
Topline Results
Disc Medicine reported positive top-line results from the APOLLO Phase III trial of bitopertin for EPP.
The big picture
Disc Medicine Inc. (IRON) announced positive top-line results from its APOLLO Phase III trial of bitopertin for EPP.
